Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2012-06-29

Clinical Trial Update: Rituximab-induced Pulmonary Function Changes

View source ↗

Summary

A clinical trial update reports changes in pulmonary function associated with rituximab in patients with rheumatoid arthritis and inflammatory myositis, highlig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituxan (rituximab) (rituximab)

Snippet

Sponsor: University of Zurich | Conditions: Rheumatoid Arthritis, Inflammatory Myositis | Status: UNKNOWN